Equity Profile

NOVT

Novanta Inc.

Information TechnologyElectronic Equipment & Instruments$5.6B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance this quarter.

N/A

Revenue Growth

Investors will look for strong revenue growth to gauge demand for Novanta's products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

NOVT Q2-2026 Earnings Preview

Context

Company Snapshot

Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments. The company plays a crucial role in providing precision motion and photonics solutions, which are essential for various industries, including medical technology and industrial automation.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+4.90%

Avg Stock Reaction

+0.95%

Last Quarter Recap

In Q1 2026, Novanta reported an EPS of $0.81, exceeding expectations by 5.19%. The stock reacted positively, gaining 1.21% the following day.

Management Promises & Guidance

Focus on expanding product offerings in precision motion and photonics.
Commitment to enhancing operational efficiency.
Plans to explore new market opportunities in medical technology.

Expectations

Wall Street Expectations

Overall, expectations are mixed as Novanta has a strong track record of beating EPS estimates, but revenue guidance remains uncertain.

Bull Case

If Novanta continues its trend of exceeding EPS expectations, it could signal robust demand and operational efficiency, leading to a positive stock reaction.

Bear Case

Conversely, any signs of slowing revenue growth or declining margins could raise concerns about the company's ability to maintain profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for the upcoming quarter?

Revenue growth is critical for assessing demand for Novanta's products and overall business health.

How is the company managing its gross margins in the current economic environment?

Gross margin trends will provide insights into cost management and pricing strategies, which are vital for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Novanta's ability to capitalize on emerging markets in medical technology, which could drive unexpected revenue growth.

Supporting Evidence

Recent insider selling could indicate a lack of confidence in short-term performance, contrasting with the bullish consensus.

Options pricing suggests a larger move than historical averages, indicating potential volatility that the market isn't fully accounting for.

Key Risk

If revenue growth comes in below 5%, it could challenge the current positive sentiment around the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on Novanta's ability to maintain growth and profitability amidst market challenges.

Bull Confirmed If

Revenue growth of 10% or more year-over-year, with gross margin holding above 50%.

Bear Confirmed If

Any revenue growth below 5% or a gross margin decline below 45%.

Pre-Earnings Positioning

Options Market

Implied Move

±9.30%

Historical Avg

±5.1%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings report.

Options are pricing ±9.3% while NOVT has averaged ±5.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

56.5%

Calls (22K)P/C Ratio: 0.05Puts (600)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$845,325.00

6,500 sh

1 insider

Net

$845,325.00

Net selling

Most Active Insiders· 1 open-market trade

Chief Executive OfficerGlastra Matthijs
$845,325.00

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Novanta beats expectations, history suggests the stock could rise by around 1.86%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line but management provides cautious commentary, the stock may experience muted reactions as investors reassess future growth.

Miss

A miss could lead to a decline of about 5.45%, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in precision motion and photonics.
2Insights into market demand trends, especially in medical technology.
3Management's outlook on operational efficiency and cost management strategies.
4Specific revenue growth targets for the upcoming quarters.
5Any commentary on competitive pressures in the electronic equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and performance this quarter.

N/A

Revenue Growth

Investors will look for strong revenue growth to gauge demand for Novanta's products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

NOVT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+4.90%

Avg Stock Reaction

+0.95%

Last Quarter Recap

In Q1 2026, Novanta reported an EPS of $0.81, exceeding expectations by 5.19%. The stock reacted positively, gaining 1.21% the following day.

Management Promises & Guidance

Focus on expanding product offerings in precision motion and photonics.
Commitment to enhancing operational efficiency.
Plans to explore new market opportunities in medical technology.

Expectations

Wall Street Expectations

Overall, expectations are mixed as Novanta has a strong track record of beating EPS estimates, but revenue guidance remains uncertain.

Bull Case

If Novanta continues its trend of exceeding EPS expectations, it could signal robust demand and operational efficiency, leading to a positive stock reaction.

Bear Case

Conversely, any signs of slowing revenue growth or declining margins could raise concerns about the company's ability to maintain profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for the upcoming quarter?

Revenue growth is critical for assessing demand for Novanta's products and overall business health.

How is the company managing its gross margins in the current economic environment?

Gross margin trends will provide insights into cost management and pricing strategies, which are vital for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Novanta's ability to capitalize on emerging markets in medical technology, which could drive unexpected revenue growth.

Supporting Evidence

Recent insider selling could indicate a lack of confidence in short-term performance, contrasting with the bullish consensus.

Options pricing suggests a larger move than historical averages, indicating potential volatility that the market isn't fully accounting for.

Key Risk

If revenue growth comes in below 5%, it could challenge the current positive sentiment around the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on Novanta's ability to maintain growth and profitability amidst market challenges.

Bull Confirmed If

Revenue growth of 10% or more year-over-year, with gross margin holding above 50%.

Bear Confirmed If

Any revenue growth below 5% or a gross margin decline below 45%.

Pre-Earnings Positioning

Options Market

Implied Move

±9.30%

Historical Avg

±5.1%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings report.

Options are pricing ±9.3% while NOVT has averaged ±5.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

56.5%

Calls (22K)P/C Ratio: 0.05Puts (600)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$845,325.00

6,500 sh

1 insider

Net

$845,325.00

Net selling

Most Active Insiders· 1 open-market trade

Chief Executive OfficerGlastra Matthijs
$845,325.00

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Novanta beats expectations, history suggests the stock could rise by around 1.86%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line but management provides cautious commentary, the stock may experience muted reactions as investors reassess future growth.

Miss

A miss could lead to a decline of about 5.45%, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in precision motion and photonics.
2Insights into market demand trends, especially in medical technology.
3Management's outlook on operational efficiency and cost management strategies.
4Specific revenue growth targets for the upcoming quarters.
5Any commentary on competitive pressures in the electronic equipment sector.